201 results on '"Vetter, Martina"'
Search Results
2. Correction: Prognostic and predictive impact of NOTCH1 in early breast cancer
3. Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients
4. PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study
5. Intrinsic subtypes in Ethiopian breast cancer patient
6. PIK3CA-mutations in breast cancer
7. Mammakarzinomrezidiv und metastasiertes Mammakarzinom
8. Blood immune profiling of Ethiopian patients with breast cancer highlights different forms of immune escape.
9. Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts
10. GRB2 is a BECN1 interacting protein that regulates autophagy
11. Human Breast Tissue Microbiota Reveals Unique Microbial Signatures that Correlate with Prognostic Features in Adult Ethiopian Women with Breast Cancer
12. Association of caspase 8 polymorphisms -652 6N InsDel and Asp302His with progression-free survival and tumor infiltrating lymphocytes in early breast cancer
13. Supplementary Figure 4 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
14. Regional variation in the tumor microenvironment, immune escape and prognostic factors in breast cancer in sub-Saharan Africa
15. Mammakarzinomrezidiv und metastasiertes Mammakarzinom
16. Supplementary Figure 2 from Cyclooxygenase-2 Is a Target Gene of Rho GDP Dissociation Inhibitor β in Breast Cancer Cells
17. Supplementary Figure 1 from Cyclooxygenase-2 Is a Target Gene of Rho GDP Dissociation Inhibitor β in Breast Cancer Cells
18. Data from Cyclooxygenase-2 Is a Target Gene of Rho GDP Dissociation Inhibitor β in Breast Cancer Cells
19. Supplementary Tables 1-5 from Cyclooxygenase-2 Is a Target Gene of Rho GDP Dissociation Inhibitor β in Breast Cancer Cells
20. Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group
21. Abstract P1-11-11: HER2-directed therapy in early breast cancer – improvement over 20 years
22. Therapie des Mammakarzinomrezidivs
23. Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients
24. Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting
25. PIK3CA mutations in breast cancer
26. Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients
27. Abstract P4-07-15: Tumor infiltrating lymphocytes as a prognostic factor
28. Abstract P2-12-05: Efficacy of neoadjuvant systemic carboplatin therapy in triple-negative breast cancer
29. Abstract P1-08-15: Communication between tumor cells and fibroblasts as a prognostic factor of NACT in TNBC
30. FNTB Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast Cancer
31. Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer
32. Assembly molding of tight mechatronic system--a model approach
33. Ets1 is an effector of protein kinase Cα in cancer cells
34. Parathyroid Hormone-related Protein Regulates Tumor-relevant Genes in Breast Cancer Cells
35. Abrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy
36. Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping
37. Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia
38. IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
39. Abstract A118: Optimization of end point PCR for the determination of ESR1, PGR, and ERBB2 expression level in resource-limited settings: Ethiopian context
40. Abstract B020: Antiproliferative efficacy of different targeted drugs on breast cancer cell lines of distinct subtypes
41. Abstract C031: NanoString nCounter-based gene expression assay for evaluation of breast cancer molecular subtypes in Ethiopian patients
42. Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts
43. Feasibility of Measuring the Prognostic Factors uPA and PAI-1 in Core Needle Biopsy Breast Cancer Specimens
44. Abstract P4-06-13: Prospective analysis of molecular subtypes in triple negative breast cancer
45. Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel
46. Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
47. Comparison of six breast cancer classifiers using qPCR
48. IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
49. Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study
50. TGF β1 regulates HGF ‐induced cell migration and hepatocyte growth factor receptor MET expression via C‐ets‐1 and miR‐128‐3p in basal‐like breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.